Pharmaceuticals, Biotechnology and Life Sciences
Company announcement – No. 74 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants…
– ARV-471 continues to show a favorable tolerability profile and robust ER degradation in updated phase 1 dose escalation data…
New data underscore efficacy of Piqray, even in those patients with a short treatment duration on prior CDK4/6i or with…
The two posters will be presented on Friday, December 10, 2021 8:00 AM to 9:30 AM EST NEW YORK, Dec.…
Partnership for Accelerating Cancer Therapies to conduct extensive biomarker analysis for ongoing phase 2 clinical trial in non-small cell lung…
Novel engineering approach accelerates generation of new antibody candidates from tRNA synthetase platform.SAN DIEGO, Dec. 10, 2021 (GLOBE NEWSWIRE) —…
Data demonstrated ONA-XR decreased proliferation in tumors with high PR+ at baseline in early breast cancer Two additional metastatic breast…
Call to discuss poster presentation on ORIC CD73 inhibitor in human ex vivo multiple myeloma systems presented at the American…
NEW YORK, Dec. 09, 2021 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery…
NEW HAVEN, Conn., Dec. 09, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical…